NCT05441202招募中不适用
The Efficacy of Transdermal Therapy for Lung nodule---an Real Word Observational Study
Chinese Chronic Respiratory Disease Research Network1 个研究点 分布在 1 个国家目标入组 10,000 人开始时间: 2022年1月1日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
- 入组人数
- 10,000
- 试验地点
- 1
- 主要终点
- change of lung nodule size
研究概览
简要总结
Incident lung nodule is quite common in China. The major treatment method is long-term floolow up without a specific intervention. We aim to investigate the efficacy an safty of a novel transdermal therapy with Chinese herb. The study included two arms: one arm is routine treatment and another arm is routine treatment plus transdermal therapy. The study end point is the change of lung nodule size under CT scan.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 80 Years(Adult, Older Adult)
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •incident lung nodule patients
排除标准
- •severe baseline conditions
结局指标
主要结局
change of lung nodule size
时间窗: three months minimal
change of lung nodule size before and after intervention
次要结局
未报告次要终点
研究者
研究点 (1)
Loading locations...
相似试验
已完成
不适用
Effect of Transcutaneous Electrical Nerve Stimulation Based on Wrist-ankle Acupuncture Theory on Postoperative Pain After Video-assisted Thoracoscopic SurgeryPostoperative PainVideo-assisted Thoracoscopic Surgery (VATS)NCT06744166Changhai Hospital156
进行中(未招募)
2 期
Serplulimab Combined With Chemotherapy in Patients With Resectable Non-small-cell Lung CancerNeoadjuvant TherapyNSCLCNCT05882513Second Affiliated Hospital, School of Medicine, Zhejiang University36
已完成
不适用
Effects of Transcutaneous Electrical Nerve Stimulation in Post-operative Lung CancerCancer, LungNCT03903276Universidade Metodista de Piracicaba20
Unknown
2 期
Toripalimab as Maintenance Therapy in Patients With Driver-gene Negative Advanced NSCLC After First-line ChemotherapyNSCLC Stage IVNCT04613804Fujian Cancer Hospital30
招募中
1 期
Almonertinib in the First-line Treatment of Patients of NSCLC With Poor Performance StatusMalignant Tumor of LungPoor Performance StatusNCT05826483Guangzhou Institute of Respiratory Disease20
